name nAnno nOverlap fc zscore pvalue adjp or CIl CIu
R-HSA-5576891 Cardiac conduction 139 7 5.09 4.86 0.00044 0.021 5.64 2.16 12.4
R-HSA-948021 Transport to the Golgi and subsequent modification 186 8 4.35 4.61 0.00049 0.021 4.81 1.98 10.1
R-HSA-5654688 SHC-mediated cascade:FGFR1 21 3 14.4 6.16 0.0011 0.023 17.2 3.19 60.1
R-HSA-5654689 PI-3K cascade:FGFR1 21 3 14.4 6.16 0.0011 0.023 17.2 3.19 60.1
R-HSA-5654693 FRS-mediated FGFR1 signaling 23 3 13.2 5.85 0.0014 0.024 15.4 2.89 53.3
R-HSA-5576893 Phase 2 - plateau phase 27 3 11.2 5.32 0.0023 0.024 12.9 2.44 43.4
R-HSA-1839124 FGFR1 mutant receptor activation 31 3 9.79 4.9 0.0034 0.024 11 2.11 36.6
R-HSA-5654687 Downstream signaling of activated FGFR1 31 3 9.79 4.9 0.0034 0.024 11 2.11 36.6
R-HSA-5654726 Negative regulation of FGFR1 signaling 33 3 9.19 4.71 0.0041 0.024 10.3 1.98 34
R-HSA-5694530 Cargo concentration in the ER 33 3 9.19 4.71 0.0041 0.024 10.3 1.98 34
R-HSA-204005 COPII (Coat Protein 2) Mediated Vesicle Transport 68 4 5.95 4.09 0.0045 0.024 6.48 1.68 17.9
R-HSA-199977 ER to Golgi Anterograde Transport 155 6 3.92 3.65 0.0043 0.024 4.23 1.49 9.77
R-HSA-397014 Muscle contraction 201 7 3.52 3.61 0.0037 0.024 3.81 1.47 8.32
R-HSA-5663202 Diseases of signal transduction 359 10 2.82 3.5 0.0028 0.024 3.08 1.41 6
R-HSA-199991 Membrane Trafficking 599 14 2.36 3.44 0.0022 0.024 2.63 1.37 4.69
R-HSA-5653656 Vesicle-mediated transport 631 14 2.24 3.23 0.0035 0.024 2.48 1.29 4.43
R-HSA-5655302 Signaling by FGFR1 in disease 38 3 7.98 4.31 0.0062 0.03 8.81 1.71 28.7
R-HSA-109704 PI3K Cascade 41 3 7.4 4.1 0.0076 0.034 8.12 1.58 26.3
R-HSA-1433557 Signaling by SCF-KIT 41 3 7.4 4.1 0.0076 0.034 8.12 1.58 26.3
R-HSA-112399 IRS-mediated signalling 42 3 7.22 4.04 0.0081 0.034 7.91 1.54 25.6
R-HSA-2428928 IRS-related events triggered by IGF1R 46 3 6.6 3.8 0.01 0.037 7.17 1.4 23
R-HSA-5576892 Phase 0 - rapid depolarisation 46 3 6.6 3.8 0.01 0.037 7.17 1.4 23
R-HSA-1226099 Signaling by FGFR in disease 47 3 6.46 3.75 0.011 0.037 7 1.37 22.5
R-HSA-2428924 IGF1R signaling cascade 47 3 6.46 3.75 0.011 0.037 7 1.37 22.5
R-HSA-2404192 Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) 48 3 6.32 3.69 0.012 0.037 6.85 1.34 21.9
R-HSA-74751 Insulin receptor signalling cascade 48 3 6.32 3.69 0.012 0.037 6.85 1.34 21.9
R-HSA-446203 Asparagine N-linked glycosylation 299 8 2.71 2.99 0.0094 0.037 2.91 1.21 6.05
R-HSA-1793185 Chondroitin sulfate/dermatan sulfate metabolism 50 3 6.07 3.59 0.013 0.038 6.56 1.28 20.9
R-HSA-5654736 Signaling by FGFR1 50 3 6.07 3.59 0.013 0.038 6.56 1.28 20.9
R-HSA-6811558 PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling 96 4 4.21 3.16 0.015 0.042 4.49 1.18 12.3
R-HSA-8856825 Cargo recognition for clathrin-mediated endocytosis 100 4 4.05 3.06 0.017 0.046 4.3 1.13 11.7
R-HSA-199418 Negative regulation of the PI3K/AKT network 103 4 3.93 2.98 0.019 0.05 4.17 1.09 11.4
